Invesco S&P 500 Pure Growth ETF (RPG US) – Portfolio Construction MethodologyThe underlying S&P 500 Pure Growth Index targets the subset of S&P 500 constituents exhibiting the strongest growth characteristics. Each S&P 500 stock receives growth and value style scores using S&P’s U.S. Style framework (growth commonly incorporates sales growth, earnings change-to-price, and price momentum; value uses book-/earnings-/sales-to-price). Only securities with 100% of their float-adjusted market cap allocated to gro ...

Core Insights - The focus is on identifying and analyzing companies that can play a significant role in current geopolitics and leverage their intellectual property to become future leaders in their sectors [1] - The investment strategy emphasizes growth companies, particularly in the mid-cap segment, with a focus on sectors such as biotechnology, computer chips, cloud technology, energy, and commodities [1] - A systematic approach will be employed, combining top-down and bottom-up analyses, including balance sheet assessments and stress tests to evaluate the safety of business models [1] - The preference is for long-term capital appreciation rather than short-term speculation [1] Sector Analysis - Biotechnology, computer chips, cloud technology, energy, and commodities are highlighted as key sectors for investment opportunities [1] - Special attention will be given to the risks associated with business cases within these sectors [1] Methodology - A systematic balance sheet analysis will be conducted, as many growing businesses may struggle with funding [1] - Stress tests will be utilized to challenge investment theses and assess the robustness of each business model [1]

Core Viewpoint - The article highlights Universal Health Services (UHS) as a strong growth stock, supported by its favorable Growth Score and Zacks Rank, indicating solid investment potential for growth investors [2][11]. Earnings Growth - Universal Health Services has a historical EPS growth rate of 10.9%, with projected EPS growth of 7.8% this year, significantly outperforming the industry average of -1.6% [5][4]. Asset Utilization Ratio - The company has an asset utilization ratio (sales-to-total-assets) of 1.14, indicating it generates $1.14 in sales for every dollar in assets, compared to the industry average of 0.82, showcasing superior efficiency [7][6]. Sales Growth - UHS is expected to achieve a sales growth of 5.2% this year, which is higher than the industry average of 4.2%, reflecting strong sales performance [8]. Earnings Estimate Revisions - The current-year earnings estimates for Universal Health Services have been revised upward, with the Zacks Consensus Estimate increasing by 0.4% over the past month, indicating positive momentum [9]. Overall Assessment - With a Zacks Rank of 2 and a Growth Score of B, Universal Health Services is positioned as a potential outperformer and a solid choice for growth investors [11].

Core Viewpoint - The article highlights Global Payments (GPN) as a recommended growth stock, emphasizing its strong earnings and cash flow growth, along with positive earnings estimate revisions, making it a solid choice for growth investors [2][11]. Earnings Growth - Global Payments has a historical EPS growth rate of 14.2%, with projected EPS growth of 13.2% for the current year, surpassing the industry average of 12.9% [5]. Cash Flow Growth - The company exhibits a year-over-year cash flow growth of 8%, which is above the industry average of 6.7%. Additionally, its annualized cash flow growth rate over the past 3-5 years stands at 17.9%, compared to the industry average of 13.1% [6][7]. Earnings Estimate Revisions - There have been upward revisions in the current-year earnings estimates for Global Payments, with the Zacks Consensus Estimate increasing by 0.1% over the past month, indicating a positive trend [9]. Overall Assessment - Global Payments has achieved a Growth Score of B and a Zacks Rank of 2, reflecting its potential as an outperformer and a strong option for growth investors [11].

Core Viewpoint - Zacks Premium provides various tools and resources to help investors make informed decisions and maximize their stock market investments Group 1: Zacks Style Scores - Zacks Style Scores are indicators that rate stocks based on value, growth, and momentum methodologies, aiding investors in selecting stocks likely to outperform the market in the next 30 days [3] - Each stock receives an alphabetic rating from A to F, with A indicating the highest potential for outperformance [4] - The Style Scores are categorized into four types: Value Score, Growth Score, Momentum Score, and VGM Score, which combines all three styles [4][5][6][7] Group 2: Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to assist investors in building successful portfolios [8] - Stocks rated 1 (Strong Buy) have historically produced an average annual return of +23.9% since 1988, significantly outperforming the S&P 500 [9] - To optimize returns, investors should focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B [10] Group 3: Company Spotlight - Ameriprise Financial Services - Ameriprise Financial, headquartered in Minneapolis, has total assets under management of $1.66 trillion as of September 30, 2025 [12] - The company holds a Zacks Rank of 3 (Hold) and a VGM Score of A, indicating solid performance potential [12] - Ameriprise has a Value Style Score of A, with a forward P/E ratio of 12.2, and has seen positive earnings estimate revisions, increasing the Zacks Consensus Estimate by $0.35 to $38.75 per share [13]

Core Insights - Intel Corporation (INTC) stock has delivered over 140% returns in the past year, indicating strong market performance [1] Group 1: Investment Strategy - The investment approach focuses on identifying attractive risk/reward opportunities supported by robust price action to generate alpha above the S&P 500 [1] - The strategy combines timely price action analysis with fundamental analysis, avoiding overhyped stocks while targeting beaten-down stocks with recovery potential [1] - The investing group Ultimate Growth Investing specializes in high-potential opportunities across various sectors, emphasizing stocks with strong growth potential and appealing turnaround plays [1]

Core Insights - The article emphasizes the importance of evaluating not only current financials but also the overall business models and future prospects of companies for long-term investment [2] Company Summaries Eli Lilly - Eli Lilly is recognized as a growth-oriented company, driven by innovation, particularly through its GLP-1 products, Mounjaro and Zepbound, which are currently generating strong results [5] - The company is actively pursuing further innovation, including the development of a GLP-1 pill and a promising weight loss treatment, retatrutide, which is in late-stage trials [5][6] - Eli Lilly has partnered with Nvidia to build a factory utilizing AI and supercomputing for drug discovery, showcasing its commitment to future growth [6] - The company also has a treatment for early Alzheimer's, Kisunla, which has the potential to be a blockbuster [7] - Despite a high valuation at over 50 times trailing earnings, the growth potential suggests that this multiple could decrease as the company expands [8] American Express - American Express is highlighted for its strong brand and clientele, making it a resilient financial stock suitable for long-term investment [8] Alphabet - Alphabet is noted for its diverse business operations, abundant growth opportunities, and substantial financial resources, positioning it as a likely growth leader in the foreseeable future [8]

Core Perspective - The investment strategy is informed by a background in the oil and gas sector, emphasizing efficiency, carefulness, and discipline in decision-making [1] Investment Focus - The company has a sustained interest in U.S. equity markets, particularly in technology, energy, and healthcare sectors [1] - The investment approach has evolved from growth investing to a blend of value and growth, focusing on the underlying economics of businesses [1] Competitive Advantage - There is an emphasis on evaluating the durability of a company's competitive advantage, referred to as its "moat," and its ability to generate consistent free cash flow over time [1] Investment Philosophy - The philosophy includes a conservative orientation, seeking to minimize downside risk while looking for upside potential [1] - As retirement approaches, there is a shift towards prioritizing income-generating assets such as dividend-paying equities and REITs [1] Community Engagement - The company values participation in a community of investors to share insights on real-world business fundamentals and intelligent investing [1] - There is a commitment to investing in ecologically sensitive businesses, reflecting a broader concern for environmental impact [1]

Company Overview - CAVA Group, Inc. is a leading fast-casual restaurant operator specializing in Mediterranean cuisine, utilizing a multi-channel approach that includes dine-in locations and retail product distribution [1] - The company aims to capture demand for healthy and customizable meals, supported by a growing national footprint and strategic integration of restaurant and retail channels [1] Stock Performance - As of January 13, 2026, CAVA shares were priced at $68.52, reflecting a decline of 38.3% over the past year, significantly underperforming the S&P 500 by 57.61 percentage points [2] - The stock has experienced a significant setback after initially soaring post-IPO in June 2023, with a decline of approximately 37% over the last 12 months [7] Institutional Investment - Nepsis Inc. increased its stake in CAVA, acquiring an additional 52,776 shares valued at approximately $2.94 million, bringing its total holding to 3.2% of its 13F reportable assets under management as of December 31, 2025 [2][4] - The total value of Nepsis's CAVA position rose by $2.88 million from the previous quarter, indicating confidence in the company's long-term growth potential [3][4] Growth Potential - CAVA is in 'growth mode', with plans to expand its restaurant footprint to over 1,000 locations by 2032, up from around 450 currently [8] - The company has launched a new menu that has been positively received by sell-side analysts, suggesting potential for a turnaround in stock performance [8] Valuation Metrics - CAVA's forward price-to-earnings (P/E) ratio stands at 124x, which, while significantly lower than its one-year high of 240x, remains high in absolute terms, indicating it is a stock for aggressive growth investors [9] - The company's ability to deliver on anticipated growth is critical, as failure to do so could lead to further declines in share price [9]

Group 1 - The analyst expresses caution regarding investments in the pharmaceutical sector due to regulatory uncertainties and unpredictable clinical trial outcomes [1] - The analyst has over 10 years of experience in the investment industry, focusing on small-cap stocks often overlooked by Wall Street [1] - The analyst is a CFA Level III candidate and holds qualifications from the Chartered Institute for Securities and Investment (CISI) [1] Group 2 - The analyst has been featured on major financial platforms such as CNBC, Bloomberg, Nasdaq, and Yahoo Finance [1] - The analyst is involved in private equity transactions, including acquiring and managing businesses [1]